U.S. markets open in 4 hours 15 minutes

Generation Bio Co. (GBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.58+1.19 (+4.69%)
At close: 4:00PM EDT

Generation Bio Co.

301 Binney Street
Cambridge, MA 02142
United States
617 655 7500
http://generationbio.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees100

Key Executives

NameTitlePayExercisedYear Born
Dr. Cameron Geoffrey McDonoughPres, CEO, Sec. & Director515.83kN/A1970
Dr. Matthew Norkunas M.B.A., M.D.Chief Financial Officer264.36kN/A1978
Dr. Tracy Zimmermann Ph.D.Chief Devel. Officer342.96kN/A1970
Dr. Robert Kotin Ph.D.Co-Founder & AdvisorN/AN/A1956
Dr. Matthew Stanton Ph.D.Chief Scientific OfficerN/AN/A1973
Dr. Jennifer Elliott Esq., J.D., Ph.D.Chief Legal OfficerN/AN/AN/A
Ms. Sara Den BestenChief People OfficerN/AN/AN/A
Dr. Douglas Kerr M.B.A., M.D., Ph.D.Chief Medical OfficerN/AN/A1967
Ms. Antoinette Paone M.B.A., M.S.Sr. VP & Head of Regulatory Affairs and QualityN/AN/AN/A
Ms. Leslie Wolfe Ph.D.Sr. VP of Chemistry, Manufacturing & ControlN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Generation Bio Co.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.